Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Karen James, MD, is a Staff Cardiologist, and a member of the transplantation team in the Sydell and Arnold Miller Family Heart & Vascular Institute at the Cleveland Clinic. She is also Director of the Heart Failure Cardio-Oncology clinic. She is board-certified as a diplomat in internal medicine, cardiovascular disease and advanced heart failure and transplant medicine. Dr. James has a special interest in cardiac transplantation, left ventricular assist devices, congestive heart failure and heart failure in patients treated for cancer.
Dr. James completed her undergraduate degree at Susquehanna University in Pennsylvania, graduating summa cum laude. She received her medical degree from Hahnemann Medical College in Philadelphia. She did her clinical training in internal medicine at Cleveland Clinic, then fellowships in peripheral vascular disease and cardiology. She was appointed to Cleveland Clinic in 1991.
Dr. James is Associate Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and discipline leader for the chronic disease management curriculum. She is principal investigator or co-investigator in many clinical trials focusing on heart failure therapies, transplant arteriosclerosis and heart failure physiology in LVAD patients, to name but a few of her many research efforts.
She is widely published in leading medical journals such as Circulation, American Heart Journal, American Journal of Cardiology and Transplantation on topics related to her specialty interests. She has written a number of chapters in medical textbooks, among them “Heart Disease arising from Pregnancy” and “Inflammatory Cardiomyopathy." Click here for a full listing of Dr. James' publications.
She is a reviewer of abstracts for publications that include Circulation Heart Failure, Journal of Heart and Lung Transplantation, Cleveland Clinic Journal of Medicine, Journal of Cardiac Failure and Arthritis and Rheumatism. She has presented the results of her research and clinical experience at national and international conferences and symposia and published numerous abstracts on her specialty interests.
Dr. James is a Fellow of the American College of Cardiology (FACC) and a member of the International Society of Heart Transplantation and of the Clinical Council of the American Heart Association.
Cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device, myocardial biopsy, cardiac catheterization
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/1/2015, Dr. James has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.